AMERIO, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 5.444
EU - Europa 5.198
AS - Asia 2.140
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 8
SA - Sud America 6
AF - Africa 5
Totale 12.817
Nazione #
US - Stati Uniti d'America 5.404
IT - Italia 1.376
CN - Cina 1.048
IE - Irlanda 976
UA - Ucraina 832
TR - Turchia 680
SE - Svezia 656
GB - Regno Unito 489
FR - Francia 361
IN - India 349
DE - Germania 242
FI - Finlandia 152
CA - Canada 35
VN - Vietnam 24
BE - Belgio 22
RO - Romania 21
EU - Europa 16
RU - Federazione Russa 15
HK - Hong Kong 10
ES - Italia 9
CH - Svizzera 8
IR - Iran 7
NL - Olanda 7
AU - Australia 6
PK - Pakistan 5
EG - Egitto 4
HU - Ungheria 4
BG - Bulgaria 3
BR - Brasile 3
CL - Cile 3
DK - Danimarca 3
GR - Grecia 3
IL - Israele 3
JP - Giappone 3
PA - Panama 3
PL - Polonia 3
TW - Taiwan 3
AT - Austria 2
LU - Lussemburgo 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AG - Antigua e Barbuda 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
KR - Corea 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
SG - Singapore 1
SM - San Marino 1
TH - Thailandia 1
UG - Uganda 1
Totale 12.817
Città #
Chandler 1.132
Jacksonville 1.023
Dublin 961
Princeton 458
Izmir 444
Dearborn 422
Southend 404
Nanjing 274
Beijing 205
Wilmington 194
Ashburn 192
Altamura 167
Cambridge 153
Nanchang 103
Ann Arbor 97
Chieti 87
Boardman 75
Shenyang 62
Woodbridge 61
Hebei 53
Norwalk 49
Kunming 48
Rome 48
New York 46
Milan 43
Tianjin 43
Torino 42
Houston 37
Jiaxing 35
Jinan 31
Washington 30
Hangzhou 27
Montesilvano 26
Seattle 26
Dong Ket 24
Falls Church 24
Santa Clara 23
Brussels 21
Grevenbroich 21
San Mateo 19
Hefei 18
Ottawa 18
Changsha 17
Alba 16
Palermo 16
Scottsdale 16
Fairfield 15
London 15
Pescara 15
Lanzhou 14
Montesilvano Marina 14
Bologna 13
Guangzhou 13
Leawood 11
Redwood City 11
Barlad 10
Frankfurt am Main 10
Ningbo 10
Augusta 9
Helsinki 9
Orange 9
Shanghai 9
Turin 9
Zhengzhou 9
Changchun 8
San Benedetto Del Tronto 8
Taizhou 8
Bari 7
Dallas 7
Giarre 7
Haikou 7
Hong Kong 7
Madrid 7
Ancona 6
Ardabil 6
Auburn Hills 6
Chicago 6
Mumbai 6
Naples 6
Pune 6
Toronto 6
Trieste 6
Andover 5
Brescia 5
Catania 5
Como 5
Duncan 5
L'aquila 5
Messina 5
Wuhan 5
Bangalore 4
Bellante 4
Bucharest 4
Campobasso 4
Caserta 4
Edinburgh 4
Francavilla Al Mare 4
Fuzhou 4
Genova 4
Grafing 4
Totale 7.736
Nome #
Calcinosi idiopatica dello scroto: descrizione di un caso 678
Pemfigo vegetante di Hallopeau . Un caso con localizzazione al vertice. 231
A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 2: Oncologic and infectious indications 121
From new scientific knowledge on rosacea to its possible medico-legal consequences 119
Psoriasi Update: Gestione del rischio infettivologico nei pazienti psoriasisci. Approfondimenti su tubercolosi ed epatite 110
Finger thermoregulatory model assessing functional impairment in Raynaud's phenomenon 103
Optimizing a clinical guidance for diagnosis of atopic dermatitis in adults: joint recommendations of the Italian Society of Dermatology and Venereology (SIDeMaST), Italian Association of Hospital Dermatologists (ADOI), and Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA) 97
Vitiligo associated with other autoimmune diseases:Polyglandular Autoimmune Syndrome type 3 B+C and 4. 96
VALUTAZIONE DELLO STRESS OSSIDATIVO NEI CARCINOMI BASOCELLULARI MULTIPLI 93
The marble child (Il Bambino di marmo) 92
Psoriasis and Alexithymia 90
Two Phase 3 Trials of dupilumab versus placebo in atopic dermatitis 89
Necrotizing fasciitis caused by Pseudomonas Aeruginosa 86
La regolazione emotiva in dermatologia psicosomatica: risultati preliminari in un progetto di ricerca multidimensionale 85
Well-differentiated squamous cell carcinoma of the penis associated with HPV type 33. 84
Drug induced cutaneous lupus erythematosus after 5 years of treatment with carbamazepine. 84
Trattamento delle verruche recidivanti con Dye laser pulsato: Nostra esperienza e revisione della letteratura 83
Extraordinary and prolonged erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: A case report 83
Terapia della psoriasi ungueale 83
A Th2-like cytokine response is involved in bullous pemphigoid. the role of IL-4 and IL-5 in the pathogenesis of the disease. 83
Topical preparations for the treatment of psoriasis: results of a retrospective study over 15 years. 83
Madura's foot: report of a case caused by Madurella mycetomatis. 83
A case of calcinosis cutis from minmal calcium extravasation 82
Molluscum contagiosum in paediatric patients: to treat or not to treat? Could a personalised Imiquimod regimen be the answer to the dilemma? 81
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept. 80
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 79
PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/practically sustainable and evidence-based algorithm. 78
Extremely low frequency electromagnetic field enhances human keratinocyte cell growth and decreases proinflammatory chemokine production 78
Atopic dermatitis treatment: What's new on the horizon? 78
Elevated 8-isoprostane levels in basal cell carcinoma and in UVA irradiated skin. 78
Extremely low-frequency electromagnetic fields accelerates wound healing modulating MMP-9 and inflammatory cytokines 77
LE ECTOPARASSITOSI NEL BAMBINO 76
A four-year old-child with widespread pyoderma gangrenosum resistant to topical treatment. 76
Extremely Low Frequency Electromagnetic Field and Cytokines Production. 76
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial 76
Bullous Wells syndrome 75
Rehabilitation approach to sclerodermia. 75
Extremely low frequency Electromagnetic fields (ELF-EMF) effect on morphology and geneticexpression profile of a human keratinocyte line (HaCaT) 75
Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications 74
Epidemiology and clinical and pathological characteristics of cutaneous malignant melanoma in Abruzzo (Italy) 74
Cutaneous lupus erythematosus mimicking multiple keratoacanthomas. 74
Kinetic Study on the Effects of Extremely Low Frequency Electromagnetic Field on Catalase, Cytochrome P450 and Inducible Nitric Oxide Synthase in Human HaCaT and THP-1 Cell Lines. 74
Carcinoma squamocellulare del pene: descrizione di un caso. 73
Psoriasi Update. Artrite Psoriasica 73
Systemic photoimmunoprotection: could a Polypodium Leucotomos extract enhance the activity of Photo Dynamic therapy on scalp Actinic keratosis. 73
In vitro effects of low frequency electromagnetic fields on Anti Microbial Peptides (AMP) expression 73
T cell receptor-Vbeta analysis identifies a dominant CD60+ CD26- CD49d- T cell clone in the peripheral blood of Sezary syndrome patients. 72
A case of persistent light reaction phenomenon to ketoprofen? 72
Very low electromagnetic field and innate immunity in HaCaT cells 72
Speed rate (SR) as a new dynamic index of melanoma behavior 72
Metastatizing dermal squamomelanocytic tumor. 71
TTG and EPD for the detection of early arthritis in Psoriasis patients 71
Collagenases are expressed during reepithelization in autoimmune bullous disorders 71
Role of cytomegalovirus replication in alopecia areata pathogenesis. 70
UV induced Immunosuppression 70
Tinea capitis due to Microsporum gypseum in an adult. 70
Metastasizing dermal squamomelanocytic tumour: More evidences 70
Photodynamic Therapy plus topical retinoids in Darier’s disease. 69
ECCRINE SYRINGOFIBROADENOMA RADIATION TREATMENT OF AN UNUSUAL PRESENTATION 69
The 72-kDa and the 92-kDa gelatinases, but not their inhibitors TIMP-1 and TIMP-2, are expressed in early psoriatic lesions. 69
Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol 69
Clinica psicosomatica nell’ambito della medicina ospedaliera. 69
Cytokine Levels and UVr Sensitivity in HaCaT Cells and Cetuximab Treated Patients. 69
Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines. 68
IL-1α, IL6 and TNF-α in cutaneous lesions of lupus erithematosus are inhibited by topical application of calcipotriol. 68
KSHV mRNA expression in tissue samples from Kaposis’s sarcoma. 68
Pemfigo eritematoso paraneoplastico in assenza di neoplasia rilevabile. 68
Cytokines and T cells in atopic dermatitis. 68
Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts 68
Nail loss after teriflunomide treatment: a new potential adverse event 68
Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. 67
Immune modulation in pemphigus vulgaris: role of CD28 and IL-10 67
Joint functional impairment and thermal alterations in patients with Psoriatic Arthritis: A thermal imaging study. 67
Circulating Adipokine Levels in Mild Psoriatic Patients 67
Sindromi psoriasiche nell’artrite psoriasica 67
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. 66
Epidemiologia della scabbia. 66
EGFR regulates the expression of keratinocyte-derived granulocyte/macrophage colony-stimulating factor in vitro and in vivo. 66
Polypodium Leucotomos Supplementation in the Treatment of Scalp Actinic Keratosis: Could It Improve the Efficacy of Photodynamic Therapy? 66
Psoriasis and migraine 66
Polyglandular autoimmune syndrome type III with a prevalence of cutaneous features 65
null 65
Serological landscape of cytokines in cutaneous melanoma 65
Psoriasis awareness among Italian patients: results of a nationwide survey 65
Assessment of Psoriatic Arthritis by Means of Functional Infrared Imaging: A Pilot Study 65
Role of Th2 cytokines, RANTES and eotaxin in AIDS-associated eosinophilic folliculitis. 64
La Psoriasi Ricerca di Base 64
L’eritrodermia nel paziente anziano 64
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 64
Mole modifications following controlled ovarian stimulation for assisted reproduction technologies 64
Validation and field performance of the Italian version of the psoriatic arthritis screening and evaluation (PASE) questionnaire 64
SERUM HMW ADIPONECTIN, RBP-4, VISFATIN, APELIN AND HMGB1 LEVELS IN MILD PSORIATIC PATIENTS 64
Application of chaos theory in the assessment of emotional vulnerability and emotion dysregulation in adults 64
Systemic effects of ingested nickel on the immune system of nickel sensitised women 63
Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. 63
Microvessel density and VEGF expression seems to correlate with invasiveness of basal cell carcinoma. 63
Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioning. 63
CARCINOMA BASOCELLULARE LINEARE. PRESENTAZIONE DI UN CASO E REVISIONE DELLA LETTERATURA. 62
'Suction split' as a routine method to differentiate epidermolysis bullosa acquisita from bullous pemphigoid. 62
Supportive care protocol and evaluation of side effects during radiotherapy concomitant to cetuximab in locally advanced head and neck cancer: a monoinstitutional experience. 62
Totale 8.195
Categoria #
all - tutte 44.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.733


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019586 0 0 0 0 0 0 0 0 0 59 29 498
2019/20202.778 690 159 28 76 253 246 426 260 78 211 326 25
2020/20211.346 219 67 216 51 121 248 43 20 63 141 81 76
2021/20221.147 36 40 25 194 112 45 25 84 104 31 127 324
2022/20233.449 310 430 196 361 329 647 204 260 418 53 178 63
2023/20241.347 107 79 97 46 88 402 383 50 61 34 0 0
Totale 13.640